Practice management in the era of anti-VEGF therapy (Part I)

Article

Identifying the bottlenecks that are preventing effective management of neovascular AMD.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
Mario Romano, MD, PhD, stresses the importance of thermodynamic control in vitrectomy during the 2025 European Society of Retina Specialists meeting. Photo shows Prof Romano on-camera at the Ophthalmology Times Europe and Modern Retina booth during EURETINA.
During the 2025 EURETINA congress, the Eye Care Network spoke with Mark Gillies, MD, PhD, director of research at the Save Sight Institute, about anti-VEGF agents.
Related Content
A black-and-white photo of an eye, underneath a digital overlay of an ocular scanner. Concept image for Eyenuk artificial intelligence screening tool for diabetic retinopathy, Norway health system rollout. Image credit: ©Lukas Gojda – stock.adobe.com

Eyenuk deploys autonomous AI eye screening technology throughout Norway

Jordana Joy
September 30th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

September 30th 2025
Podcast
A hand writes a check mark in a box. It is superimposed over an image of samples in a laboratory. Image credit: ©everythingpossible – stock.adobe.com

European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9)

Martin David Harp
September 30th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

September 30th 2025
Podcast
EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

Sydney M Crago
September 30th 2025
Article
A movie theatre with empty seats. The screen has reels of film negatives, with a blue tint, and the words "Coming Soon" in large yellow letters. Image credit: Created with Canva. Components via Photology2000 and Ron Lach, Pexels.

EURETINA industry previews: Beacon Therapeutics, Nanoscope Therapeutics and Valitor

Kassi Filkins
September 30th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.